Aspire Biopharma Holdings (ASBP) Prepaid Assets (2022 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Prepaid Assets came in at $890149.0 in Q1 2026, up 43.81% year-on-year from $618971.0 in Q1 2025, and up 1515.46% on a QoQ basis from $55102.0 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Prepaid Assets (2022 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 5 years of Prepaid Assets data on file, last reported at $890149.0 in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 43.81% year-over-year to $890149.0 in Q1 2026; TTM through Mar 2026 was $890149.0, a 43.81% increase from a year earlier, with the FY2025 full-year figure at $55102.0, down 61.83% from the prior year.
- Prepaid Assets for Q1 2026 stood at $890149.0, up from $55102.0 in the prior quarter.
- Over the last five years, Prepaid Assets for ASBP reached as high as $890149.0 in Q1 2026 and fell as low as $43052.0 in Q2 2024.
- Historically, Prepaid Assets has averaged $428390.5 across 5 years, with a median of $506123.0 in 2023.
- Across the five-year window, Prepaid Assets slumped 89.77% in 2024 and jumped 1719.17% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $600493.0 in 2022, then plunged by 86.47% to $81223.0 in 2023, then soared by 77.73% to $144356.0 in 2024, then tumbled by 61.83% to $55102.0 in 2025, then surged by 1515.46% to $890149.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $890149.0 in Q1 2026, $55102.0 in Q4 2025, and $419421.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 890,149.00 |
| Dec 31, 2025 | 55,102.00 |
| Sep 30, 2025 | 419,421.00 |
| Jun 30, 2025 | 783,189.00 |
| Mar 31, 2025 | 618,971.00 |
| Dec 31, 2024 | 144,356.00 |
| Jun 30, 2024 | 43,052.00 |
| Mar 31, 2024 | 65,577.00 |
| Dec 31, 2023 | 81,223.00 |
| Sep 30, 2023 | 253,082.00 |
| Jun 30, 2023 | 420,943.00 |
| Mar 31, 2023 | 591,303.00 |
| Dec 31, 2022 | 600,493.00 |
| Sep 30, 2022 | 613,357.00 |
| Jun 30, 2022 | 629,129.00 |
| Mar 31, 2022 | 644,901.00 |